Myeloid leukemias are among the most aggressive blood cancers and have low survival rates. Today, leukemia patients undergo ...

▎药明康德内容团队编辑（来源：武汉大学）急性髓系白血病（AML）是一种由造血干/祖细胞遗传异常引发的血液系统恶性肿瘤，其致病因素主要包括染色体易位和基因突变等遗传变异。除急性早幼粒细胞白血病外，AML普遍存在治疗手段有限、复发率高、死亡率高等问题，导 ...

A study demonstrates that the 'previous state' of blood stem cells plays a decisive role in the subtype of leukemia that develops. The new technique, called STRACK, allows monitoring of the evolution ...

Aptose Biosciences advances its Phase 1/2 TUSCANY trial, escalating tuspetinib dosing after a favorable safety review. Enrollment continues across U.S. sites.

Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety ...

In this video, Stephen M. Ansell, MD, PhD professor of medicine, chair of the division of hematology, co-leader of the hematological malignancies program, and interim chair of the department of ...

急性髓系白血病（AML）是一种常见的造血系统恶性肿瘤，其特征为未成熟白血病细胞在骨髓中的过度增殖，并伴随正常血细胞生成受阻。尽管近年来AML的治疗有所进展，但由于其高度异质性、疗效有限以及高复发率，AML患者的五年生存率依然较低。AML的病理机制研究 ...

Figure 1: Pathological findings and flow cytometric analysis of lymphoma cells in Tax transgenic mice.

After hours: February 21 at 5:57:25 PM EST Loading Chart for APVO ...